Prednisone for inflammatory cardiomyopathy: more than just an immunosuppressive agent

Eur Heart J. 2023 Apr 17;44(15):1374-1375. doi: 10.1093/eurheartj/ehad068.

Authors

Zhiqiang Yang¹, Yue Li², Chao Liu^{1

3}

Affiliations

¹ Heart Center, The First Hospital of Hebei Medical University, Hebei Medical University, 89 Donggang Road, Shijiazhuang, Hebei Province 050031, China.
² Heart Center, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, Hebei 050000, China.
³ Cardiovascular Research Center of Hebei Medical University, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Shijiazhuang 050017, China.

PMID: 36804688
DOI: 10.1093/eurheartj/ehad068

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunosuppressive Agents* / therapeutic use
Myocarditis* / drug therapy
Myocardium
Prednisone / therapeutic use

Substances

Immunosuppressive Agents
Prednisone